| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0503817-0ABRPI0503817A (en) | 2005-09-12 | 2005-09-12 | immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens |
| ES06775036TES2423892T3 (en) | 2005-09-12 | 2006-09-12 | Immune complex formed by vaccine antigens encapsulated with nanostructured mesoporous silica |
| US12/066,489US8642258B2 (en) | 2005-09-12 | 2006-09-12 | Immunogenical complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| KR1020087007043AKR101089400B1 (en) | 2005-09-12 | 2006-09-12 | Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| CN2006800383996ACN101287491B (en) | 2005-09-12 | 2006-09-12 | Immunogenic complexes formed from vaccine antigens encapsulated using nanostructured mesoporous silica |
| PCT/BR2006/000182WO2007030901A1 (en) | 2005-09-12 | 2006-09-12 | Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| EP06775036.4AEP1942934B1 (en) | 2005-09-12 | 2006-09-12 | Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| HK09102975.6AHK1124791B (en) | 2005-09-12 | 2006-09-12 | Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| CA2621373ACA2621373C (en) | 2005-09-12 | 2006-09-12 | Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| JP2008530281AJP5091863B2 (en) | 2005-09-12 | 2006-09-12 | Immunogenic complexes consisting of vaccine antigens incorporated into nanostructured mesoporous silica |
| ZA200802277AZA200802277B (en) | 2005-09-12 | 2008-03-10 | Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0503817-0ABRPI0503817A (en) | 2005-09-12 | 2005-09-12 | immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens |
| Publication Number | Publication Date |
|---|---|
| BRPI0503817Atrue BRPI0503817A (en) | 2007-05-15 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0503817-0ABRPI0503817A (en) | 2005-09-12 | 2005-09-12 | immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens |
| Country | Link |
|---|---|
| US (1) | US8642258B2 (en) |
| EP (1) | EP1942934B1 (en) |
| JP (1) | JP5091863B2 (en) |
| KR (1) | KR101089400B1 (en) |
| CN (1) | CN101287491B (en) |
| BR (1) | BRPI0503817A (en) |
| CA (1) | CA2621373C (en) |
| ES (1) | ES2423892T3 (en) |
| WO (1) | WO2007030901A1 (en) |
| ZA (1) | ZA200802277B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018102896A1 (en)* | 2016-12-05 | 2018-06-14 | Universidade Estadual De Campinas - Unicamp | Vaccine forhaemophilus aegypus and use |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0503817A (en) | 2005-09-12 | 2007-05-15 | Cristalia Prod Quimicos Farm | immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens |
| AU2006326405B2 (en) | 2005-12-13 | 2013-10-31 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
| US9770535B2 (en) | 2007-06-21 | 2017-09-26 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
| CN102006891B (en) | 2008-02-13 | 2017-04-26 | 哈佛学院董事会 | Continuous cell programming device |
| US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
| US9012399B2 (en) | 2008-05-30 | 2015-04-21 | President And Fellows Of Harvard College | Controlled release of growth factors and signaling molecules for promoting angiogenesis |
| DE102008033175A1 (en)* | 2008-07-15 | 2010-01-21 | Merck Patent Gmbh | Silica nanoparticles and their use for vaccination |
| JP2010083834A (en)* | 2008-10-01 | 2010-04-15 | Naris Cosmetics Co Ltd | Allergen inactivator and cosmetic product containing the same |
| US9297005B2 (en) | 2009-04-13 | 2016-03-29 | President And Fellows Of Harvard College | Harnessing cell dynamics to engineer materials |
| EP2461828B1 (en) | 2009-07-31 | 2017-06-21 | President and Fellows of Harvard College | Programming of cells for tolerogenic therapies |
| WO2011109834A2 (en) | 2010-03-05 | 2011-09-09 | President And Fellows Of Harvard College | Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
| US9693954B2 (en) | 2010-06-25 | 2017-07-04 | President And Fellows Of Harvard College | Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| PL2624873T3 (en) | 2010-10-06 | 2020-12-14 | President And Fellows Of Harvard College | Injectable, pore-forming hydrogels for materials-based cell therapies |
| WO2012064697A2 (en) | 2010-11-08 | 2012-05-18 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
| WO2012148684A1 (en) | 2011-04-27 | 2012-11-01 | President And Fellows Of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| EP3417876B1 (en) | 2011-04-28 | 2021-03-31 | President and Fellows of Harvard College | Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration |
| US9486512B2 (en) | 2011-06-03 | 2016-11-08 | President And Fellows Of Harvard College | In situ antigen-generating cancer vaccine |
| CN103012594B (en)* | 2011-09-22 | 2015-09-02 | 中国农业科学院兰州兽医研究所 | A kind of nano-carrier and application delivering pig circular ring virus epitope protein |
| JP5999639B2 (en)* | 2011-11-25 | 2016-09-28 | 国立研究開発法人産業技術総合研究所 | Immunostimulating factor-bearing microparticle |
| EP2838515B1 (en)* | 2012-04-16 | 2019-11-20 | President and Fellows of Harvard College | Mesoporous silica compositions for modulating immune responses |
| ES2821528T3 (en) | 2012-11-14 | 2021-04-26 | Grace W R & Co | Compositions containing a biologically active material and an unordered inorganic oxide |
| EP2981249A4 (en)* | 2013-04-02 | 2016-11-23 | Stc Unm | Mesoporous alum nanoparticles as universal platform for antigen adsorption, presentation, and delivery |
| AU2014366842B2 (en)* | 2013-12-19 | 2018-10-04 | The University Of Queensland | Method of synthesis of silica vesicles and use thereof |
| WO2015168379A2 (en) | 2014-04-30 | 2015-11-05 | President And Fellows Of Harvard College | Combination vaccine devices and methods of killing cancer cells |
| CN105267970A (en)* | 2015-01-08 | 2016-01-27 | 浙江大学 | Thermostable vaccine with silica on surface and preparation method therefor |
| CA3012602A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
| WO2016164705A1 (en) | 2015-04-10 | 2016-10-13 | Omar Abdel-Rahman Ali | Immune cell trapping devices and methods for making and using the same |
| JP6868862B2 (en)* | 2015-08-31 | 2021-05-12 | 国立研究開発法人産業技術総合研究所 | Mesoporous silica particles |
| CN105597094A (en)* | 2015-12-31 | 2016-05-25 | 河南农业大学 | Pig transmissible gastroenteritis virus nanometer silicon adjuvant inactivated vaccine and preparation method thereof |
| WO2017120504A1 (en) | 2016-01-08 | 2017-07-13 | Durfee Paul N | Osteotropic nanoparticles for prevention or treatment of bone metastases |
| CN115531609A (en) | 2016-02-06 | 2022-12-30 | 哈佛学院校长同事会 | Remodeling hematopoietic niches to reconstitute immunity |
| CN115404196A (en) | 2016-07-13 | 2022-11-29 | 哈佛学院院长等 | Antigen-presenting cell mimic scaffold and methods for its preparation and use |
| JP7274214B2 (en) | 2016-08-02 | 2023-05-16 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Biomaterials for modulating immune responses |
| GB2552704A (en)* | 2016-08-04 | 2018-02-07 | Univ Bath | Biomolecule preservation |
| CN106727426A (en)* | 2016-12-08 | 2017-05-31 | 中国药科大学 | A kind of preparation method for oral protein immune carrier |
| US11344629B2 (en) | 2017-03-01 | 2022-05-31 | Charles Jeffrey Brinker | Active targeting of cells by monosized protocells |
| WO2020061129A1 (en) | 2018-09-19 | 2020-03-26 | President And Fellows Of Harvard College | Compositions and methods for labeling and modulation of cells in vitro and in vivo |
| US12252708B2 (en) | 2018-09-24 | 2025-03-18 | Unm Rainforest Innovations | Living mammalian cells modified with functional modular nanoparticles |
| US12208164B2 (en) | 2019-02-28 | 2025-01-28 | Unm Rainforest Innovations | Modular metal-organic polyhedra superassembly compositions |
| CN114377120B (en)* | 2022-01-10 | 2023-09-22 | 大连理工大学 | Construction and application of silica vaccine delivery system with virus-like particles as templates |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102643A (en) | 1990-01-25 | 1992-04-07 | Mobil Oil Corp. | Composition of synthetic porous crystalline material, its synthesis |
| US5057296A (en) | 1990-12-10 | 1991-10-15 | Mobil Oil Corp. | Method for synthesizing mesoporous crystalline material |
| AU7881000A (en) | 1999-08-16 | 2001-03-13 | Henceforth Hibernia, Inc. | Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| US20020051794A1 (en) | 2000-08-09 | 2002-05-02 | Alk-Abello A/S | Novel parenteral vaccine formulations and uses thereof |
| GB0118689D0 (en)* | 2001-08-01 | 2001-09-19 | Psimedica Ltd | Pharmaceutical formulation |
| CN1193818C (en)* | 2002-03-13 | 2005-03-23 | 华东理工大学 | Silicone dioxide magnetic microsphere and its preparation method |
| US20040005352A1 (en)* | 2002-04-16 | 2004-01-08 | Lopez Gabriel P. | Biologically functionalized porous microspheres |
| JP2004083501A (en)* | 2002-08-28 | 2004-03-18 | Toyota Central Res & Dev Lab Inc | Stabilized antibody, immunoreaction method and immunoreaction device using the same |
| JP2004155745A (en)* | 2002-11-08 | 2004-06-03 | Kumamoto Technology & Industry Foundation | Peptide and its use |
| US20040101822A1 (en)* | 2002-11-26 | 2004-05-27 | Ulrich Wiesner | Fluorescent silica-based nanoparticles |
| JP2004321010A (en)* | 2003-04-21 | 2004-11-18 | Japan Science & Technology Agency | Novel streptococcal protein antigen |
| US20060018966A1 (en)* | 2003-07-22 | 2006-01-26 | Lin Victor S | Antimicrobial mesoporous silica nanoparticles |
| US7563451B2 (en)* | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
| JP4429105B2 (en)* | 2003-08-19 | 2010-03-10 | キヤノン株式会社 | Organic substance-immobilized structure and production method thereof, peptide and DNA |
| BRPI0503817A (en) | 2005-09-12 | 2007-05-15 | Cristalia Prod Quimicos Farm | immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018102896A1 (en)* | 2016-12-05 | 2018-06-14 | Universidade Estadual De Campinas - Unicamp | Vaccine forhaemophilus aegypus and use |
| Publication number | Publication date |
|---|---|
| KR101089400B1 (en) | 2011-12-07 |
| EP1942934B1 (en) | 2013-05-01 |
| JP5091863B2 (en) | 2012-12-05 |
| ZA200802277B (en) | 2009-01-28 |
| HK1124791A1 (en) | 2009-07-24 |
| CN101287491A (en) | 2008-10-15 |
| CA2621373C (en) | 2014-05-27 |
| JP2009507859A (en) | 2009-02-26 |
| CN101287491B (en) | 2013-01-30 |
| ES2423892T3 (en) | 2013-09-25 |
| WO2007030901A1 (en) | 2007-03-22 |
| US20080286371A1 (en) | 2008-11-20 |
| US8642258B2 (en) | 2014-02-04 |
| CA2621373A1 (en) | 2007-03-22 |
| EP1942934A1 (en) | 2008-07-16 |
| KR20080047569A (en) | 2008-05-29 |
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0503817A (en) | immunogenic complex formed by nanostructured silica mesoporous encapsulated vaccine antigens | |
| Shah et al. | Overview of vaccine adjuvants: introduction, history, and current status | |
| Azmi et al. | Recent progress in adjuvant discovery for peptide-based subunit vaccines | |
| Puggioni et al. | Monophosphoryl lipid A (MPL®)* promotes allergen‐induced immune deviation in favour of Th1 responses | |
| TW200722101A (en) | Novel composition | |
| EA200900024A1 (en) | Anti-throat vaccine | |
| Pfaar et al. | Adjuvants for immunotherapy | |
| Klimek et al. | Clinical use of adjuvants in allergen-immunotherapy | |
| Martiñón et al. | Chemical and immunological characteristics of aluminum‐based, oil‐water emulsion, and bacterial‐origin adjuvants | |
| CY1113546T1 (en) | WATER OIL MILK EMULSIONS AND VACCINATION COMPOSITIONS | |
| BRPI0206672B8 (en) | immunological composition, tetravalent conjugate vaccine and multivalent meningococcal vaccine | |
| DK2468300T3 (en) | Vaccine composition containing synthetic adjuvant | |
| KR20130112790A (en) | Vaccine composition | |
| Pérez et al. | New vaccines require potent adjuvants like AFPL1 and AFCo1 | |
| EP2455101A3 (en) | Influenza vaccine with oil-in-water emulsion adjuvant | |
| EP2481422A3 (en) | Multiplex vaccines | |
| WO2007068907A3 (en) | Vaccine compositions comprising a saponin adjuvant | |
| JP2014531396A (en) | Pharmaceutical composition containing a combination of a selective carrier, vitamin, tannin and flavonoid as an antigen-specific immune modulator | |
| BR0314373A (en) | Stable immunogenic product for the induction of antibodies to one or more antigenic proteins in a subject, pharmaceutical, immunogenic and vaccine compositions and process of preparation of an immunogenic product | |
| Burakova et al. | Food‐Grade Saponin Extract as an Emulsifier and Immunostimulant in Emulsion‐Based Subunit Vaccine for Pigs | |
| BRPI0515334A (en) | use of a plasmodium antigen | |
| GB2442408A (en) | Vaccine adjuvants | |
| Pérez et al. | Natural Neisseria derive proteoliposome and cochleate as potent vaccine adjuvants | |
| BR112014012184A2 (en) | malaria vaccine | |
| Sohrabi et al. | Evaluation of immune response against leishmaniasis in resistance C57 BL/6 mice immunized with liposomes containing autoclaved Leishmania major with BCG |
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | Free format text:PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/07/2017, OBSERVADAS AS CONDICOES LEGAIS. | |
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time | ||
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) | Free format text:EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2479 DE 10-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |